Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Combined diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) secondary to immune checkpoint inhibitors (ICIs) is extremely rarely reported among ICIs- diabetes mellitus (DM) cases and is always ignored by physicians. This study aimed to conduct a systematic review to recognize better the rare adverse event of combined DKA-HHS associated with immune checkpoints.
Methods: A electronic search in Pubmed/Cochrane/Web of Science, complemented by manual searches in article references, was conducted to identify clinical features of ICIs-combined DKA-HHS.
Results: we identified 106 patients with ICIs- type 1 diabetes mellitus (T1DM) from 82 publications: 9 patients presented a coexistence of metabolic acidosis, severe hyperglycemia, and/or DKA; All patients were not diagnosed as combined DKA-HHS. Compared with ICIs-DKA patients, combined DKA-HHS cases were prone to higher hyperglycemia (1020 ± 102.5 vs 686.7 ± 252.6mg/dL). Moreover, acute kidney injury (87.5% vs 28.6%) and prior chemotherapy (66.7% vs 31.6%) showed higher occurrences with the onset of ICIs-HHS or combined DKA-HHS.B.
Conclusions: Combined DKA-HHS portends a poor diagnosis in patients with coexistence features of DKA and HHS, which healthcare professionals and patients should be aware of due to differences in treatment. Our observational retrospective case series shows that patients with more risk factors were more likely to develop combined DKA-HHS. We are the first to report this group of patients' clinical characteristics and outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846077 | PMC |
| http://dx.doi.org/10.3389/fendo.2022.1084441 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Characteristics and Hypokalemia Risk Prediction in Patients With Hyperosmolar Hyperglycemic State and Diabetic Ketoacidosis (HHS-DKA): A Single-Center, Retrospective Observational Study.
Cureus
May 2025
Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, JPN.
Background: People with combined diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) often present with more severe metabolic derangements than those with DKA or HHS alone. This study aimed to clarify the clinical characteristics of HHS-DKA and explore predictive models for complications, including hypokalemia.
Methods: We retrospectively analyzed data from 99 patients admitted with hyperglycemic emergencies between April 1, 2010, and October 31, 2024, and classified them into DKA, HHS, and HHS-DKA groups.
Pleiotropic Effects of Cocaine Abuse in Hyperglycemic Crisis: Main Culprit or Accomplice but Never an Innocent Bystander.
Clin Med Insights Endocrinol Diabetes
June 2025
Nephrology Department, Garden City Hospital, Michigan State University, USA.
Hyperglycemic crises, including diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS), significantly affect clinical outcomes and impose a heavy economic burden. Among the steadily increased recreational drug abuse, cocaine has become the most frequently misused substance. However, there is limited understanding of the relationship between cocaine use and hyperglycemic crises.
View Article and Find Full Text PDFThe effect of renal function on the clinical outcomes and management of patients hospitalized with hyperglycemic crises.
Front Endocrinol (Lausanne)
January 2025
Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Background: The global prevalence of diabetes has been rising rapidly in recent years, leading to an increase in patients experiencing hyperglycemic crises like diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS). Patients with impaired renal function experience a delay in insulin clearance, complicating the adjustment of insulin dosing and elevating hypoglycemia risk. Accordingly, this study aims to evaluate the impact of renal function on the safety and efficacy of insulin use in patients with isolated DKA or combined DKA/HHS.
View Article and Find Full Text PDFRisk of chronic kidney disease in patients with a hyperglycemic crisis as the initial presentation of type 2 diabetes.
Sci Rep
July 2024
International Master Program for Public Health, China Medical University, Taichung, 406040, Taiwan.
Article Synopsis
- A study was conducted using data from Taiwanese insurance claims to evaluate the long-term impact of hyperglycemic crisis (HC) on the development of chronic kidney disease (CKD) in newly diagnosed type 2 diabetes patients.* -
- The findings revealed that patients experiencing HC at diagnosis had a significantly higher incidence of CKD compared to those without HC, with a two-fold risk increase.* -
- The risk of CKD was found to be highest in patients with combined diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS), indicating that tailored medical interventions are essential for this high-risk group.*
Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM.
Front Endocrinol (Lausanne)
January 2023
Department of Respiratory and Critical Care Medicine, Shanghai Changhai Hospital, the First Affiliated Hospital of Naval Medical University, Shanghai, China.
Background: Combined diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) secondary to immune checkpoint inhibitors (ICIs) is extremely rarely reported among ICIs- diabetes mellitus (DM) cases and is always ignored by physicians. This study aimed to conduct a systematic review to recognize better the rare adverse event of combined DKA-HHS associated with immune checkpoints.
Methods: A electronic search in Pubmed/Cochrane/Web of Science, complemented by manual searches in article references, was conducted to identify clinical features of ICIs-combined DKA-HHS.